CGEM·230031106·US·equity·Healthcare - Biotechnology-13D/G
CGEM (CULLINAN THERAPEUTICS INC) is held by 92 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($63.2M), STATE STREET CORP ($36.2M), RTW INVESTMENTS, LP ($24.2M). Net institutional sentiment: Mixed.
See how CGEM's score breaks down across 4 SEC sources
Showing 1-20 of 99
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer